Výsledky vyhľadávania - "Fumarates/therapeutic use"
-
1
Autori: a ďalší
Zdroj: Adv Ther
Predmety: Adult, Male, Brief Report, Dimethyl Fumarate, Middle Aged, Magnetic Resonance Imaging, Multiple Sclerosis, Relapsing-Remitting, Treatment Outcome, Fumarates, Double-Blind Method, Disease Progression, Humans, Female, Double-Blind Method [MeSH], Female [MeSH], Disease Progression [MeSH], Adult [MeSH], Diroximel fumarate, Disease-modifying therapies, Humans [MeSH], Dimethyl fumarate, Treatment Outcome [MeSH], Fumarates/therapeutic use [MeSH], Middle Aged [MeSH], Dimethyl Fumarate/therapeutic use [MeSH], Efficacy, Re-baselining, No Evidence of Disease Activity (NEDA), Magnetic Resonance Imaging [MeSH], Multiple sclerosis, Male [MeSH], Multiple Sclerosis, Relapsing-Remitting/drug therapy [MeSH], Fumarates/pharmacology [MeSH], Immunosuppressive Agents/therapeutic use [MeSH], Immunosuppressive Agents
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38878121
https://repository.publisso.de/resource/frl:6501302 -
2
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Drug Des Devel Ther
Predmety: Fumarates / therapeutic use, 0301 basic medicine, viral suppression, Hepatitis B virus, Tenofovir / adverse effects, Antiviral Agents / adverse effects, Antiviral Agents, viral DNA, 03 medical and health sciences, Hepatitis B, Chronic, Fumarates, antiviral agents, Humans, Viral, Hepatitis B e Antigens, Tenofovir, 0303 health sciences, Drug Design, Development and Therapy, Adenine, bone density, DNA, Tablets / therapeutic use, Viral Load, Hepatitis B, 3. Good health, Adenine / adverse effects, Treatment Outcome, Chronic* / drug therapy, Clinical Trial Report, Creatinine, DNA, Viral, Tablets
Popis súboru: text/html; application/octet-stream
-
3
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: HIV Medicine. 22:623-628
Predmety: Alanine / adverse effects, Fumarates / therapeutic use, Male, Hepatitis, Viral, Human, Tenofovir / adverse effects, Anti-HIV Agents, 610 Medicine & health, HIV Infections, 10234 Clinic for Infectious Diseases, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Fumarates, Tenofovir disoproxil fumarate, 2736 Pharmacology (medical), Humans, Tenofovir alafenamide, Tenofovir, Alanine, HIV, Alanine Transaminase, 2725 Infectious Diseases, Middle Aged, 2719 Health Policy, HIV Infections / drug therapy, 3. Good health, Alanine aminotransferase, Anti-HIV Agents / adverse effects, Tenofovir / analogs & derivatives, Switzerland
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/33880839
https://europepmc.org/article/MED/33880839
https://onlinelibrary.wiley.com/doi/full/10.1111/hiv.13106
https://pubmed.ncbi.nlm.nih.gov/33880839/
https://www.zora.uzh.ch/id/eprint/207400/
https://archive-ouverte.unige.ch/unige:161490
https://doi.org/10.1111/hiv.13106
https://www.zora.uzh.ch/id/eprint/207400/
https://doi.org/10.5167/uzh-207400 -
4
Autori: Alabas, OA
Zdroj: Alabas, OA 2023, 'The real-world effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for treating moderate-to-severe psoriasis', British Journal of Dermatology, vol. 188, no. 5, pp. e35. https://doi.org/10.1093/bjd/ljad092
Predmety: Acitretin/therapeutic use, Cohort Studies, Cyclosporine/therapeutic use, Fumarates/therapeutic use, Humans, Methotrexate/therapeutic use, Psoriasis/drug therapy
-
5
Autori: a ďalší
Predmety: Adipose Tissue/drug effects, Adipose Tissue/metabolism, Adult, Amides/pharmacology, Amides/therapeutic use, Amlodipine/pharmacology, Amlodipine/therapeutic use, Angiotensin II/metabolism, Antihypertensive Agents/pharmacology, Antihypertensive Agents/therapeutic use, Blood Glucose/drug effects, Double-Blind Method, Female, Fumarates/pharmacology, Fumarates/therapeutic use, Glucose/metabolism, Humans, Hypertension/blood, Hypertension/drug therapy, Hypertension/etiology, Hypertension/metabolism, Insulin/blood, Lipolysis/drug effects, Male, Microdialysis, Middle Aged, Muscle, Skeletal/drug effects, Skeletal/metabolism, Obesity/blood
Relation: Journal of the American Society of Hypertension; https://iris.unil.ch/handle/iris/226152; serval:BIB_82F1124E75DA; 000408288300006
-
6
Autori: a ďalší
Predmety: Adult, Aged, Amides/pharmacology, Amides/therapeutic use, Antihypertensive Agents/pharmacology, Antihypertensive Agents/therapeutic use, Female, Fumarates/pharmacology, Fumarates/therapeutic use, Humans, Hydrochlorothiazide/pharmacology, Hydrochlorothiazide/therapeutic use, Hypertension/diagnosis, Hypertension/drug therapy, Kidney/drug effects, Kidney/metabolism, Male, Middle Aged, Oxygen Consumption/drug effects, Oxygen Consumption/physiology, Prospective Studies, Renin/antagonists & inhibitors, Single-Blind Method
Relation: Kidney and Blood Pressure Research; https://iris.unil.ch/handle/iris/206052; serval:BIB_E3EA18BB8ACD; 000364209500010
-
7
Autori: a ďalší
Prispievatelia: a ďalší
Predmety: Aged, Amides/adverse effects, Amides/therapeutic use, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/mortality, Diabetes Mellitus, Type 2/complications, Type 2/drug therapy, Double-Blind Method, Drug Therapy, Combination, Female, Follow-Up Studies, Fumarates/adverse effects, Fumarates/therapeutic use, Humans, Hyperkalemia/chemically induced, Hypokalemia, Kidney Diseases/epidemiology, Kidney Diseases/etiology, Male, Middle Aged, Patient Dropouts, Renin/antagonists & inhibitors, Treatment Failure
Relation: New England Journal of Medicine; https://iris.unil.ch/handle/iris/190729; serval:BIB_AA678180CBF9; 000311890600007
-
8
Autori:
Predmety: Dimethyl Fumarate, Drug Therapy, Combination, Female, Fumarates/administration & dosage, Fumarates/adverse effects, Fumarates/therapeutic use, Humans, Middle Aged, Recurrence, Stomatitis, Aphthous/drug therapy, Aphthous/pathology
Relation: Archives of dermatology; https://iris.unil.ch/handle/iris/147455; serval:BIB_B50CCD210D32; 000288611200002
-
9
Autori: a ďalší
Predmety: Aged, 80 and over, Amides/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents/therapeutic use, COVID-19/complications, Female, Fumarates/therapeutic use, Humans, Hypertension/drug therapy, Male, Renin/antagonists & inhibitors, Retrospective Studies, Aliskiren, Angiotensin converting enzyme inhibitor, Angiotensin Ⅱ receptor antagonist, Calcium channel antagonist, Coronavirus disease 2019, Hypertension
Relation: Zhonghua nei ke za zhi; https://iris.unil.ch/handle/iris/54812; serval:BIB_3AA1A7F89D3F
-
10
Autori: a ďalší
Zdroj: Pharmacological Reports. 67:173-178
Predmety: Male, Platelet Aggregation, Blood Pressure, Thrombosis - complications, Disease models, Hemostasis - drug effects, Hypertension - complications, Amides - pharmacology, 03 medical and health sciences, Hypertension - drug therapy, 0302 clinical medicine, Fumarates, Plasminogen Activator Inhibitor 1, Blood coagulation - drug effects, Animals, animal, Plasminogen activator inhibitor 1 - blood, Antihypertensive agents - therapeutic use, Blood Coagulation, Antihypertensive Agents, Blood coagulation factors - drug effects, Thrombosis - blood, Amides - therapeutic use, Hemostasis, Tissue plasminogen activator - blood, Blood pressure - drug effects, Thrombosis, Thrombosis - drug therapy, Amides, Blood Coagulation Factors, Rats, 3. Good health, Disease Models, Animal, Platelet aggregation - drug effects, Antihypertensive agents - pharmacology, Tissue Plasminogen Activator, Fumarates - pharmacology, Hypertension, Fumarates - therapeutic use
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/25712636
https://www.sciencedirect.com/science/article/pii/S1734114014002825#!
https://pubmed.ncbi.nlm.nih.gov/25712636/
https://www.ncbi.nlm.nih.gov/pubmed/25712636
https://www.sciencedirect.com/science/article/pii/S1734114014002825
https://europepmc.org/article/MED/25712636
https://link.springer.com/article/10.1016/j.pharep.2014.08.021 -
11
Autori:
Zdroj: ISSN: 1660-9379 ; Revue médicale suisse, vol. 14, no. 588-589 (2018) p. 27-29.
Predmety: info:eu-repo/classification/ddc/616, info:eu-repo/classification/ddc/616.07, Dietary Supplements, Esters, Fumarates/therapeutic use, Humans, Multiple Sclerosis/diet therapy, Psoriasis/diet therapy
Relation: info:eu-repo/semantics/altIdentifier/pmid/29337444; unige:126178
Dostupnosť: https://archive-ouverte.unige.ch/unige:126178
-
12
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: New England Journal of Medicine, Vol. 367, no.12, p. 1098-107 (2012)
Predmety: Adult, Male, 0301 basic medicine, Immunosuppressive agents - adverse effects, Double-blind method, Kaplan-Meier estimate, Dimethyl Fumarate, Medizin, Administration, Oral, Kaplan-Meier Estimate, Infections, Dimethyl fumarate, Multiple sclerosis, oral, 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, 0302 clinical medicine, Double-Blind Method, Fumarates, oral BG-12, relapsing multiple sclerosis, Humans, Middle aged, Immunosuppressive agents - administration & dosage, Fumarates - administration & dosage, Brain, relapsing-remitting - pathology, Middle Aged, relapsing-remitting - drug therapy, 3. Good health, Brain - pathology, Fumarates - adverse effects, Infection - etiology, Administration, Female, Infection, Fumarates - therapeutic use, Immunosuppressive Agents, Immunosuppressive agents - therapeutic use
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/22992073
http://www.nejm.org/doi/full/10.1056/NEJMoa1114287
https://doi.org/10.1056/NEJMoa1114287
https://cris.maastrichtuniversity.nl/en/publications/1c9ffec7-56e2-4c89-9230-3d1c4aee3697
https://doi.org/10.1056/NEJMoa1114287
https://www.nejm.org/doi/abs/10.1056/NEJMoa1114287
https://europepmc.org/article/MED/22992073
https://www.nejm.org/doi/full/10.1056/NEJMoa1114287
https://www.bib.irb.hr/673649
http://www.bib.irb.hr/673649
https://dial.uclouvain.be/pr/boreal/object/boreal:124401
https://hdl.handle.net/2078.1/124401 -
13
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: The New England journal of medicine, Vol. 367, no. 12, p. 1087-97 (2012)
Predmety: Adult, Male, 0301 basic medicine, Immunosuppressive agents - adverse effects, Double-blind method, Dimethyl Fumarate, Administration, Oral, Peptides - adverse effects, Infections, Dimethyl fumarate, Intention to treat analysis, Multiple sclerosis, oral, 03 medical and health sciences, Glatiramer acetate, Magnetic resonance imaging, Multiple Sclerosis, Relapsing-Remitting, 0302 clinical medicine, Double-Blind Method, Fumarates, Humans, Middle aged, Immunosuppressive agents - administration & dosage, Fumarates - administration & dosage, Brain, relapsing-remitting - pathology, Glatiramer Acetate, Middle Aged, relapsing-remitting - drug therapy, Magnetic Resonance Imaging, Intention to Treat Analysis, 3. Good health, Brain - pathology, Peptides - therapeutic use, Fumarates - adverse effects, Infection - etiology, Administration, Female, Infection, Peptides, Fumarates - therapeutic use, Immunosuppressive Agents, Immunosuppressive agents - therapeutic use
Prístupová URL adresa: https://univoak.eu/islandora/object/islandora%3A63662/datastream/PDF/view
https://pubmed.ncbi.nlm.nih.gov/22992072
https://www.nejm.org/doi/abs/10.1056/NEJMoa1206328
https://www.ncbi.nlm.nih.gov/pubmed/22992072
https://pubmed.ncbi.nlm.nih.gov/22992072/
https://www.nejm.org/doi/full/10.1056/NEJMoa1206328#t=article
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1206328
https://dial.uclouvain.be/pr/boreal/object/boreal:124404
https://hdl.handle.net/2078.1/124404 -
14
Autori: a ďalší
Zdroj: Journal of Investigative Dermatology, Vol. 132, No 9 (2012) pp. 2206-14
Predmety: Keratinocytes, Male, 0301 basic medicine, p38 Mitogen-Activated Protein Kinases/metabolism, Homeostasis/drug effects/immunology, Interleukin-1beta, Interleukin-1beta/analysis/immunology, Insulin Resistance/immunology, Psoriasis/drug therapy/immunology, Dermatology, Epidermis/drug effects/immunology, Biochemistry, p38 Mitogen-Activated Protein Kinases, Cell Proliferation/drug effects, 03 medical and health sciences, 0302 clinical medicine, Fumarates, Homeostasis, Humans, Psoriasis, Molecular Biology, Cells, Cultured, Cell Proliferation, Keratinocytes/drug effects/immunology/physiology, Fumarates/therapeutic use, Cell Biology, 3. Good health, Female, Epidermis, Insulin Resistance
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/22513786
https://www.ncbi.nlm.nih.gov/pubmed/22513786
https://archive-ouverte.unige.ch/unige:29220
https://www.sciencedirect.com/science/article/pii/S0022202X15358826
http://www.readcube.com/articles/10.1038/jid.2012.123
https://www.jidonline.org/article/S0022-202X(15)35882-6/fulltext
https://pubmed.ncbi.nlm.nih.gov/22513786/
https://archive-ouverte.unige.ch/unige:29220 -
15
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Journal of Urology. 186:694-701
Predmety: Amides/therapeutic use, Male, 0301 basic medicine, Nephritis/drug therapy, renin-angiotensin system, Inbred C57BL, Kidney, Nephritis/etiology, Fumarates/therapeutic use, ureteral obstruction, Mice, 03 medical and health sciences, 0302 clinical medicine, Fumarates, Renin/antagonists & inhibitors, Renin, Animals, Nephritis, fibrosis, Kidney/pathology, Amides, Fibrosis, 3. Good health, Mice, Inbred C57BL, inflammation, Fibrosis/etiology, Ureteral Obstruction/complications, Fibrosis/drug therapy, aliskiren, Ureteral Obstruction
Popis súboru: 694~701
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21683401
http://europepmc.org/abstract/MED/21683401
https://www.sciencedirect.com/science/article/pii/S002253471103535X
https://www.jurology.com/article/S0022-5347(11)03535-X/pdf
https://pubmed.ncbi.nlm.nih.gov/21683401/
https://ir.ymlib.yonsei.ac.kr/handle/22282913/93466
https://www.auajournals.org/doi/10.1016/j.juro.2011.03.122 -
16
Autori: a ďalší
Zdroj: Journal of the European Academy of Dermatology and Venereology, Vol. 25, No 10 (2011) pp. 1187-1193
Predmety: Adult, Male, Methotrexate/therapeutic use, Receptors, Tumor Necrosis Factor/therapeutic use, Immunoglobulin G/therapeutic use, Antibodies, Monoclonal, Humanized, Etanercept, 03 medical and health sciences, 0302 clinical medicine, Adipokines, Fumarates, Risk Factors, Resistin/*blood, Humans, Psoriasis, Longitudinal Studies, Prospective Studies, Biological Markers/blood, Adipokines/blood, Cyclosporine/therapeutic use, Aged, Fumarates/therapeutic use, Psoriasis/*blood/*drug therapy, Adalimumab, C-Reactive Protein/*metabolism, Cardiovascular Diseases/blood/*epidemiology, Middle Aged, 3. Good health, Treatment Outcome, C-Reactive Protein, Methotrexate, Antibodies, Monoclonal, Humanized/therapeutic use, Vascular Endothelial Growth Factor A/*blood, Cardiovascular Diseases, Immunoglobulin G, Cyclosporine, Female, Severity of Illness Index, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21241371
https://core.ac.uk/display/60776874
https://europepmc.org/article/MED/21241371
https://archive-ouverte.unige.ch/unige:29845
https://www.ncbi.nlm.nih.gov/pubmed/21241371
https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2010.03947.x
https://archive-ouverte.unige.ch/unige:29845 -
17
Autori: a ďalší
Zdroj: Archives of Dermatological Research, Vol. 303, No 6 (2011) pp. 381-388
Predmety: Adult, Male, Risk, Vascular Endothelial Growth Factor A, Biological Markers/metabolism, Pilot Projects, Cardiovascular Diseases/*drug therapy/etiology/pathology/physiopathology, Psoriasis/complications/*drug therapy/pathology/physiopathology, 03 medical and health sciences, 0302 clinical medicine, Fumarates, Humans, Psoriasis, Prospective Studies, Aged, Inflammation, Fumarates/*therapeutic use, C-Reactive Protein/metabolism, Vascular Endothelial Growth Factor A/metabolism, Middle Aged, 3. Good health, Endothelium, Vascular/*drug effects/immunology/metabolism/pathology, C-Reactive Protein, Cardiovascular Diseases, Disease Progression, Female, Endothelium, Vascular, Biomarkers, Follow-Up Studies
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21170539
https://www.ncbi.nlm.nih.gov/pubmed/21170539
https://link.springer.com/content/pdf/10.1007%2Fs00403-010-1108-6.pdf
https://europepmc.org/article/MED/21170539
https://archive-ouverte.unige.ch/unige:29795
https://link.springer.com/article/10.1007%2Fs00403-010-1108-6
https://archive-ouverte.unige.ch/unige:29795
https://doi.org/10.1007/s00403-010-1108-6
https://archive-ouverte.unige.ch/unige:29795 -
18
Autori: a ďalší
Zdroj: Kappos, L, Gold, R, Miller, D H, MacManus, D G, Havrdova, E, Limmroth, V, Polman, C H, Schmierer, K, Yousry, T A, Yang, M H, Eraksoy, M, Meluzinova, E, Rektor, I, Dawson, K T, Sandrock, A W & O'Neill, G N 2008, 'Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study', Lancet, vol. 372, no. 9648, pp. 1463-1472. https://doi.org/10.1016/S0140-6736(08)61619-0
Predmety: Adult, Male, Immunosuppressive agents - adverse effects, Patient Dropouts, Dose-response relationship, Double-blind method, Adolescent, Drug-Related Side Effects and Adverse Reactions, Dimethyl Fumarate, Administration, Oral, Klinikai orvostudományok, Dimethyl fumarate, Drug-related side effects and adverse reactions, Multiple sclerosis, oral, 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, 0302 clinical medicine, Double-Blind Method, Fumarates, Humans, Middle aged, Immunosuppressive agents - administration & dosage, Dose-Response Relationship, Drug, patient dropouts, Fumarates - administration & dosage, drug, Orvostudományok, Middle Aged, relapsing-remitting - drug therapy, 3. Good health, Fumarates - adverse effects, Administration, Female, Fumarates - therapeutic use, Immunosuppressive Agents, Immunosuppressive agents - therapeutic use
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/18970976
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61619-0/fulltext
https://is.muni.cz/publication/815442/cs/Efficacy-and-safety-of-oral-fumarate-in-patients-with-relapsing-remitting-multiple-sclerosis-a-multicentre-randomised-double-blind-placebo-controlled-phase-IIb-study/Kappos-Gold-H-Miller-G-MacManus
https://pubmed.ncbi.nlm.nih.gov/18970976/
http://www.sciencedirect.com/science/article/pii/S0140673608616190
https://europepmc.org/article/MED/18970976
http://swepub.kb.se/bib/swepub:oai:prod.swepub.kib.ki.se:117778441
https://research.vumc.nl/en/publications/bf0ff8c6-f25a-4d13-b822-61cc7a5030c9
https://pure.amsterdamumc.nl/en/publications/f6bd52c3-d661-40db-a371-99bafd76653b
https://doi.org/10.1016/S0140-6736(08)61619-0 -
19
Autori: Buczko, Włodzimierz
Zdroj: Pharmacological Reports. 60(5):623-631
Predmety: Amides - pharmacokinetics, Amides - therapeutic use, Antihypertensive agents - pharmacokinetics, Fumarates - pharmacokinetics, Drug interactions, Amides - pharmacology, Hypertension - drug therapy, Fumarates - adverse effects, Renin - antagonists & inhibitors, Renin-angiotensin system - drug effects, Antihypertensive agents - pharmacology, Fumarates - pharmacology, Renin - blood, Animals, Humans, Antihypertensive agents - adverse effects, Amides - adverse effects, Antihypertensive agents - therapeutic use, Fumarates - therapeutic use
-
20
Autori: a ďalší
Zdroj: Circulation: Heart Failure. 10
Predmety: Male, Amides/therapeutic use, Cohort Studies, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, Enalapril, Fumarates, Natriuretic Peptide, Enalapril/therapeutic use, Atrial Fibrillation, Natriuretic Peptide, Brain, Heart Failure/blood, Humans, 14. Life underwater, Cardiovascular Diseases/mortality, Antihypertensive Agents, Hospitalization/statistics & numerical data, Aged, Heart Failure, Antihypertensive Agents/therapeutic use, Fumarates/therapeutic use, Aminobutyrates, Biphenyl Compounds, Stroke Volume, Middle Aged, Prognosis, Amides, Angiotensin Receptor Antagonists/therapeutic use, 3. Good health, Hospitalization, Drug Combinations, Aminobutyrates/therapeutic use, Cardiovascular Diseases, Tetrazoles/therapeutic use, Case-Control Studies, Atrial Fibrillation/blood, Female, Brain/blood, Peptide Fragments/blood
Popis súboru: application/pdf
Prístupová URL adresa: https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.117.004409
https://pubmed.ncbi.nlm.nih.gov/29018174
https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.117.004409
https://www.ncbi.nlm.nih.gov/pubmed/29018174
http://circheartfailure.ahajournals.org/content/10/10/e004409.abstract
http://circheartfailure.ahajournals.org/content/10/10/e004409
https://researchbank.acu.edu.au/cgi/viewcontent.cgi?article=10014&context=fhs_pub
https://europepmc.org/article/MED/29018174
https://acuresearchbank.acu.edu.au/item/87q39/prognostic-value-of-n-terminal-pro-b-type-natriuretic-peptide-levels-in-heart-failure-patients-with-and-without-atrial-fibrillation
Nájsť tento článok vo Web of Science
Full Text Finder